(Q35015851)

5 August 2017

1 reference

title

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential (English)

1 reference

5 August 2017

M A Stanley

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

Clinical and Experimental Dermatology

5 August 2017

published in

1 reference

5 August 2017

volume

27

1 reference

5 August 2017

issue

7

1 reference

5 August 2017

page(s)

571-577

1 reference

Decoding the patterns of self and nonself by the innate immune system

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Immunomodulating and antiviral activities of the imidazoquinoline S-28463.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Reduction of recurrent HSV disease using imiquimod alone or combined with a glycoprotein vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Immunological events in regressing genital warts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Imiquimod 5% cream in the treatment of Bowen's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Successful topical immunotherapy of bowenoid papulosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Treatment of Bowen's disease of the penis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Detection of human papillomavirus and response to topical 5% imiquimod in a case of stucco keratosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

Porokeratosis of Mibelli: successful treatment with 5% imiquimod cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2002.01151.X

10.1046/J.1365-2230.2002.01151.X

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference